- Home
- CLRB vs EVGN Comparison
CLRB vs EVGN Comparison
Compare CLRB & EVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLRB
- EVGN
- Stock Information
- Founded
- CLRB 2002
- EVGN 1999
- Country
- CLRB United States
- EVGN Israel
- Employees
- CLRB N/A
- EVGN N/A
- Industry
- CLRB Biotechnology: Pharmaceutical Preparations
- EVGN Agricultural Chemicals
- Sector
- CLRB Health Care
- EVGN Industrials
- Exchange
- CLRB Nasdaq
- EVGN Nasdaq
- Market Cap
- CLRB 14.2M
- EVGN 11.4M
- IPO Year
- CLRB N/A
- EVGN N/A
- Fundamental
- Price
- CLRB $4.44
- EVGN $1.21
- Analyst Decision
- CLRB Hold
- EVGN Strong Buy
- Analyst Count
- CLRB 2
- EVGN 1
- Target Price
- CLRB N/A
- EVGN $3.50
- AVG Volume (30 Days)
- CLRB 113.2K
- EVGN 90.5K
- Earning Date
- CLRB 08-14-2025
- EVGN 08-19-2025
- Dividend Yield
- CLRB N/A
- EVGN N/A
- EPS Growth
- CLRB N/A
- EVGN N/A
- EPS
- CLRB N/A
- EVGN N/A
- Revenue
- CLRB N/A
- EVGN $6,765,000.00
- Revenue This Year
- CLRB N/A
- EVGN N/A
- Revenue Next Year
- CLRB N/A
- EVGN $113.18
- P/E Ratio
- CLRB N/A
- EVGN N/A
- Revenue Growth
- CLRB N/A
- EVGN N/A
- 52 Week Low
- CLRB $4.36
- EVGN $0.95
- 52 Week High
- CLRB $68.70
- EVGN $4.29
- Technical
- Relative Strength Index (RSI)
- CLRB 35.40
- EVGN 45.00
- Support Level
- CLRB $4.72
- EVGN $1.18
- Resistance Level
- CLRB $5.09
- EVGN $1.36
- Average True Range (ATR)
- CLRB 0.38
- EVGN 0.07
- MACD
- CLRB 0.09
- EVGN -0.00
- Stochastic Oscillator
- CLRB 3.42
- EVGN 34.78
About CLRB Cellectar Biosciences Inc.
Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. It has one operating and reportable segment focused on utilizing its PDC platform to develop drugs for the treatment of cancer.
About EVGN Evogene Ltd
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment, followed by Industry.